S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
2 stocks that faded their price gaps after crushing earnings
Give up the OPEC fight with these 3 stocks, Buffett-certified
Important info on NVDA trade (Ad)
10-year yield is below 4.5%...these dividend growth yields aren’t
AI revolution: 3 stocks set to soar as technology evolves
Important info on NVDA trade (Ad)
Is there money hiding under these 2 mattress stocks?
3 reasons a squeeze could be in Paramount's coming attractions
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
2 stocks that faded their price gaps after crushing earnings
Give up the OPEC fight with these 3 stocks, Buffett-certified
Important info on NVDA trade (Ad)
10-year yield is below 4.5%...these dividend growth yields aren’t
AI revolution: 3 stocks set to soar as technology evolves
Important info on NVDA trade (Ad)
Is there money hiding under these 2 mattress stocks?
3 reasons a squeeze could be in Paramount's coming attractions
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
2 stocks that faded their price gaps after crushing earnings
Give up the OPEC fight with these 3 stocks, Buffett-certified
Important info on NVDA trade (Ad)
10-year yield is below 4.5%...these dividend growth yields aren’t
AI revolution: 3 stocks set to soar as technology evolves
Important info on NVDA trade (Ad)
Is there money hiding under these 2 mattress stocks?
3 reasons a squeeze could be in Paramount's coming attractions
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
2 stocks that faded their price gaps after crushing earnings
Give up the OPEC fight with these 3 stocks, Buffett-certified
Important info on NVDA trade (Ad)
10-year yield is below 4.5%...these dividend growth yields aren’t
AI revolution: 3 stocks set to soar as technology evolves
Important info on NVDA trade (Ad)
Is there money hiding under these 2 mattress stocks?
3 reasons a squeeze could be in Paramount's coming attractions

Calnex Solutions Share Price, News & Analysis (LON:CLX)

GBX 74
+1.50 (+2.07%)
(As of 04:57 AM ET)
Compare
Today's Range
72
74
50-Day Range
41
120
52-Week Range
40
197
Volume
35,201 shs
Average Volume
197,347 shs
Market Capitalization
£64.76 million
P/E Ratio
2,466.67
Dividend Yield
1.35%
Price Target
GBX 110

Calnex Solutions MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
48.6% Upside
GBX 110 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.12mentions of Calnex Solutions in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.02 out of 5 stars


CLX stock logo

About Calnex Solutions Stock (LON:CLX)

Calnex Solutions plc designs, produces, and markets test instrumentation and solutions for network synchronization, and network emulation for telecoms networks, enterprise networks, and data centers in the Americas, North Asia, and internationally. The company offers Calnex SNE-X, a solution for the problem of ethernet testing; Paragon-neo, a platform that provides PTP and SyncE testing to 400GbE and sub-nanosecond accuracy for 5G networks; Paragon-X, a solution to test SyncE, PTP, and NTP mechanisms, as well as E1/T1 sync interfaces and ethernet OAM; Sentinel, a field solution for 3G/4G/5G mobile backhaul, E911/critical infrastructure, financial networks, and power comms; SNE Ignite, a network emulation for 5G O-RAN; Sentry, a solution for remotely monitoring multiple NTP, PTP, and clock signals in data center networks; Calnex SNE, a solution for network emulation and simulation; and NE-ONE, a performance test application for realistic networks, including LAN, WAN, Internet, Cloud, Wi-Fi, (A)DSL, mobile, and satellite to verify application performance. It also provides Paragon-ONE, a feature that bundles delivering test solutions for PTP to profiles, such as IEEE 802.1AS/AS-REV, SMPTE 2059-2, and ITU-T G.8275.1.; Attero-100G for 100/40/25GbE device performance testing; Attero-X, a network test solution; Attero-V, a virtual impairments tool that extends and complements the capabilities of the Spirent range of virtualization products and solutions; Tempo for canned tests for embedded GPS/GLONASS/BEDOU receiver and optional mini rubidium; Rb/GPS, a frequency reference that provides a stable 10MHz and a 1pps measurement reference for Sync testers; 1pps/ToD/Frequency Converter that converts timing signals; and Calnex Analysis Tool, a network and device analysis software. It offers its products through a network of resellers and distributors. The company was incorporated in 2006 and is headquartered in Linlithgow, the United Kingdom.

CLX Stock Price History

CLX Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Calnex Solutions plc (CSO.F)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
CLX.L - Calnex Solutions plc
Clorox (NYSE: CLX)
CLX The Clorox Company
3 AIM shares that are worth a look right now
See More Headlines
Receive CLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calnex Solutions and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 8/30 Dividend
7/27/2023
Dividend Payable
8/30/2023
Today
11/28/2023
Ex-Dividend for 12/15 Dividend
11/30/2023
Dividend Payable
12/15/2023

Industry, Sector and Symbol

Industry
Communication Equipment
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
155
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 110
High Stock Price Target
GBX 110
Low Stock Price Target
GBX 110
Potential Upside/Downside
+48.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
£3.10 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£22.57 million
Cash Flow
GBX 7.40 per share
Book Value
GBX 31 per share

Miscellaneous

Free Float
N/A
Market Cap
£64.76 million
Optionable
Not Optionable
Beta
1.82
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report














CLX Stock Analysis - Frequently Asked Questions

Should I buy or sell Calnex Solutions stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Calnex Solutions in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CLX shares.
View CLX analyst ratings
or view top-rated stocks.

What is Calnex Solutions' stock price target for 2024?

1 analysts have issued 1 year price targets for Calnex Solutions' stock. Their CLX share price targets range from GBX 110 to GBX 110. On average, they predict the company's stock price to reach GBX 110 in the next twelve months. This suggests a possible upside of 48.6% from the stock's current price.
View analysts price targets for CLX
or view top-rated stocks among Wall Street analysts.

How have CLX shares performed in 2023?

Calnex Solutions' stock was trading at GBX 168 at the beginning of 2023. Since then, CLX stock has decreased by 56.0% and is now trading at GBX 74.
View the best growth stocks for 2023 here
.

How often does Calnex Solutions pay dividends? What is the dividend yield for Calnex Solutions?

Calnex Solutions announced a dividend on Tuesday, November 21st. Shareholders of record on Thursday, November 30th will be paid a dividend of GBX 0.31 per share on Friday, December 15th. This represents a dividend yield of 0.5%. The ex-dividend date of this dividend is Thursday, November 30th. The official announcement can be viewed at this link.
Read our dividend analysis for CLX
.

Is Calnex Solutions a good dividend stock?

Calnex Solutions (LON:CLX) pays an annual dividend of GBX 1 per share and currently has a dividend yield of 1.36%. The dividend payout ratio is 3,333.33%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for CLX.

How do I buy shares of Calnex Solutions?

Shares of CLX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:CLX) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -